lisa burnapp (ppt, 745kb, opens in new window)

14
INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION What Choices? Lisa Burnapp Consultant Nurse Directorate of Nephrology, Transplantation and Urology Guy’s and St Thomas’ NHS Foundation Trust London, UK [email protected]

Upload: ringer21

Post on 18-Jun-2015

320 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Lisa Burnapp (ppt, 745kb, opens in new window)

INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION

What Choices?

Lisa BurnappConsultant Nurse

Directorate of Nephrology, Transplantation and Urology Guy’s and St Thomas’ NHS Foundation Trust

London, [email protected]

Page 2: Lisa Burnapp (ppt, 745kb, opens in new window)

Our Responsibility

To optimise• Patient outcome• Transplant outcome• Planning• Opportunity & choice• Use of kidneys• Donor safety & well-being• The health economy

Page 3: Lisa Burnapp (ppt, 745kb, opens in new window)

The Challenge

More

• Patients

• Choice & capability

• Expectation

• Complex

• Ethnically diverse

Page 4: Lisa Burnapp (ppt, 745kb, opens in new window)

New Trends in Living Donor Transplantation

Page 5: Lisa Burnapp (ppt, 745kb, opens in new window)

Extended Criteria (High-Risk) Recipients

‘Recipients at a significantly higher risk ofdeath, complications or graft failure becauseof pre-existing co-morbidity orimmunological status’1

High-risk includes– Immunological/ABO incompatibility– The elderly– Significant co-morbidity– Primary disease 1 Guidelines for Living Donor Kidney Transplantation in High-

Risk Adult Recipients, 2008 www.bts.org.uk

Page 6: Lisa Burnapp (ppt, 745kb, opens in new window)

High-Risk Recipients: Our Approach

• Living donation treatment of choice• All patients provided with information early • Evidence and/or lack of evidence shared with

recipient and donor• Risk benefit analysis discussed• Tailored management plan agreed • Peer support

Page 7: Lisa Burnapp (ppt, 745kb, opens in new window)

Who Makes the Choice?

• Patient & family?– What is best for them

• Healthcare professionals?– Most clinically effective– Outcome reporting– What is feasible/available– Local logistics/infrastructure– Financial constraints

• Primary care Trusts/Commissioners?– Health economics– National Guidance (NICE)

Page 8: Lisa Burnapp (ppt, 745kb, opens in new window)

Incompatible Living Kidney Donation

Page 9: Lisa Burnapp (ppt, 745kb, opens in new window)

Tailored Option Appraisal

• Do nothing– Acceptable if recipient & donor informed of possible options

• Paired/pooled donation

• Antibody removal strategies (ABO/HLA)

• Offer neither– Lack of equity

Page 10: Lisa Burnapp (ppt, 745kb, opens in new window)

Paired/Pooled Donation

• Compatible living donor transplant• Clinically more straightforward• Logistically challenging • Uncertainty about timing & ‘matchability’• Donors & recipients unknown to one another

– indirect donation

Page 11: Lisa Burnapp (ppt, 745kb, opens in new window)

Antibody Removal Strategies (ABO/HLA)

• More complex scenarios• ^ intervention (recipient)• ^ immunosuppression• Higher risk of failure

– spectrum of risk

• Time specific• Donor known to recipient

– direct donation

Page 12: Lisa Burnapp (ppt, 745kb, opens in new window)
Page 13: Lisa Burnapp (ppt, 745kb, opens in new window)

Summary

• Evolving field• Clinically challenging• Physically & psychologically demanding for

patients & their families• Compatible transplantation always the

preferred option• Outcomes encouraging

Page 14: Lisa Burnapp (ppt, 745kb, opens in new window)

Thank you